Mackay Shields LLC’s ANI Pharmaceuticals ANIP Stock Holding History

Mackay Shields LLC’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,200	Closed	-$297K	–	741
2021 Q1	$297K	Sell	8,200 -6,100	-43%	-$191K	﹤0.01%	1332
2020 Q4	$415K	Buy	+14,300	New	+$410K	﹤0.01%	1291
2020 Q2	–	Sell	-6,527	Closed	-$266K	–	1462
2020 Q1	$266K	Buy	6,527 +1,500	+30%	+$79.8K	﹤0.01%	1240
2019 Q4	$310K	Sell	5,027 -42,500	-89%	-$2.82M	﹤0.01%	1227
2019 Q3	$3.46M	Sell	47,527 -800	-2%	-$59.9K	0.02%	669
2019 Q2	$3.97M	Buy	48,327 +43,314	+864%	+$3.08M	0.03%	628
2019 Q1	$354K	Sell	5,013 -8,288	-62%	-$488K	﹤0.01%	1248
2018 Q4	$599K	Sell	13,301 -7,899	-37%	-$414K	﹤0.01%	1099
2018 Q3	$1.2M	Sell	21,200 -31,900	-60%	-$1.95M	0.01%	832
2018 Q2	$3.55M	Buy	53,100 +25,300	+91%	+$1.58M	0.02%	594
2018 Q1	$1.62M	Buy	+27,800	New	+$1.76M	0.01%	848

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return

Mackay Shields LLC's ANIP Position: Q2 2021 in Review

Mackay Shields LLC sold out of ANI Pharmaceuticals (ANIP) in Q2 2021, closing a stake of 8,200 shares — an estimated $297K sold.

Mackay Shields LLC first reported a position in ANIP in Q1 2018 and held it in 11 quarters. The position peaked at $3.97M in Q2 2019. 116 funds tracked by Wall St. Rank hold ANIP as of Q2 2021.

Mackay Shields LLC reported no remaining ANI Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Mackay Shields LLC sold 8,200 ANI Pharmaceuticals shares in Q2 2021, an estimated $297K.
Mackay Shields LLC first reported a position in ANI Pharmaceuticals in Q1 2018 and held it in 11 quarters.
Mackay Shields LLC's ANI Pharmaceuticals position peaked at $3.97M in Q2 2019.
116 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.